Author: Kaitlyn Grosse

Filter by

News

Seattle Startup Lumen Biosciences to Build Algae Manufacturing Plant in Former Bakery

Posted onJuly 19, 2021 Last Updated: July 19, 2021
By: Kaitlyn Grosse

News

Seattle-Based Icosavax, Which is Developing COVID-19 Vaccines, Files for IPO 4 Years After Launch

Posted onJuly 19, 2021 Last Updated: July 19, 2021
By: Kaitlyn Grosse

News

Absci’s IPO Reflects Booming Biotech Market and Growing PNW Life Sciences Industry

Posted onJuly 12, 2021 Last Updated: July 12, 2021
By: Kaitlyn Grosse

News

Report: Seattle’s Life Sciences Industry Continues to Boom

Posted onJuly 12, 2021 Last Updated: July 12, 2021
By: Kaitlyn Grosse

News

Vancouver, Washington Biotech Company Absci Files to Go Public

Posted onJuly 6, 2021 Last Updated: July 6, 2021
By: Kaitlyn Grosse

COVID

Seattle’s HDT Bio to Start U.S. Clinical Trials of its COVID-19 Vaccine Candidate

Posted onJuly 6, 2021 Last Updated: July 6, 2021
By: Kaitlyn Grosse

News

Washington’s Best Workplaces of 2021 Revealed

Posted onJune 28, 2021 Last Updated: June 28, 2021
By: Kaitlyn Grosse

News

Sujal Patel-led Nautilus Biotechnology Goes Public as it Tackles Ambitious Plan to Analyze Proteins

Posted onJune 21, 2021 Last Updated: June 21, 2021
By: Kaitlyn Grosse

News

Seattle Ranked #1 U.S. City for LGBTQ+ Employees

Posted onJune 15, 2021 Last Updated: June 15, 2021
By: Kaitlyn Grosse

News

Fueled by COVID Drug Manufacturing Revenues, CDMO Jubilant HollisterStier Invests in Upgrades, Expansion

Posted onJune 15, 2021 Last Updated: June 15, 2021
By: Kaitlyn Grosse